231 related articles for article (PubMed ID: 28608155)
21. A clinical perspective on gastric neuroendocrine neoplasia.
Lawrence B; Kidd M; Svejda B; Modlin I
Curr Gastroenterol Rep; 2011 Feb; 13(1):101-9. PubMed ID: 21080245
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist.
Martinsen TC; Kawase S; Håkanson R; Torp SH; Fossmark R; Qvigstad G; Sandvik AK; Waldum HL
Carcinogenesis; 2003 Dec; 24(12):1887-96. PubMed ID: 12949047
[TBL] [Abstract][Full Text] [Related]
23. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
24. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
[TBL] [Abstract][Full Text] [Related]
25. Gastric neuroendocrine tumors in a 2-year oncogenicity study with CD-1 mice.
Thoolen B; Koster H; van Kolfschoten A; de Haan M
Toxicol Pathol; 2002; 30(3):322-7. PubMed ID: 12051549
[TBL] [Abstract][Full Text] [Related]
26. Cell and tumour biology of the gastric enterochromaffin-like cell.
Modlin IM; Tang LH
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S117-30. PubMed ID: 10604115
[TBL] [Abstract][Full Text] [Related]
27. [Gastrin and gastrin receptor].
Chiba T
Nihon Rinsho; 1996 Apr; 54(4):1083-6. PubMed ID: 8920678
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
[TBL] [Abstract][Full Text] [Related]
29. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats.
Fjeldbo CS; Bakke I; Erlandsen SE; Holmseth J; Lægreid A; Sandvik AK; Thommesen L; Bruland T
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G21-33. PubMed ID: 21995960
[TBL] [Abstract][Full Text] [Related]
30. Gastric Neuroendocrine Tumors (Carcinoids).
Gluckman CR; Metz DC
Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
[TBL] [Abstract][Full Text] [Related]
31. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
32. Gastrin: from pathophysiology to cancer prevention and treatment.
Maddalo G; Spolverato Y; Rugge M; Farinati F
Eur J Cancer Prev; 2014 Jul; 23(4):258-63. PubMed ID: 24469263
[TBL] [Abstract][Full Text] [Related]
33. The gastrin hypothesis. Implications for antisecretory drug selection.
Karnes WE; Walsh JH
J Clin Gastroenterol; 1990; 12 Suppl 2():S7-12. PubMed ID: 2246496
[TBL] [Abstract][Full Text] [Related]
34. CHRONIC USE OF PROTON PUMP INHIBITORS AND THE QUANTITY OF G, D, AND ECL CELLS IN THE STOMACH.
Camilo SMP; Almeida ÉCS; Sousa JB; Camilo LP; Etchebehere RM
Arq Bras Cir Dig; 2020; 33(2):e1506. PubMed ID: 32844883
[TBL] [Abstract][Full Text] [Related]
35. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach.
Håkanson R; Böttcher G; Sundler F; Vallgren S
Digestion; 1986; 35 Suppl 1():23-41. PubMed ID: 3539678
[TBL] [Abstract][Full Text] [Related]
36. Follow-up of patients with ECL cell-derived tumours.
Sagatun L; Fossmark R; Jianu CS; Qvigstad G; Nordrum IS; Mjønes P; Waldum HL
Scand J Gastroenterol; 2016 Nov; 51(11):1398-405. PubMed ID: 27309188
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor.
Dickson JH; Grabowska A; El-Zaatari M; Atherton J; Watson SA
Cancer Res; 2006 Aug; 66(15):7524-31. PubMed ID: 16885350
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of the gastric mucosa. II. Role of gastrin in gastric epithelial cell proliferation and maturation.
Jain RN; Samuelson LC
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G762-5. PubMed ID: 17030897
[TBL] [Abstract][Full Text] [Related]
39. Clinical aspects of ECL-cell abnormalities.
Hirschowitz BI
Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
[TBL] [Abstract][Full Text] [Related]
40. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
